Stephen H. Sands is Director of Cyteir Therapeutics, Inc.. Currently has a direct ownership of 12,129 shares of CYT, which is worth approximately $36,508. The most recent transaction as insider was on Feb 09, 2024, when has been sold 12,129 shares (Common Stock) at a price of $1.69 per share, resulting in proceeds of $20,498. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.1K
0% 3M change
n/a 12M change
Total Value Held $36,508

Stephen H. Sands Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 09 2024
BUY
Exercise of conversion of derivative security
$20,498 $1.69 p/Share
12,129 Added 50.0%
12,129 Common Stock

Also insider at

BCYC
BICYCLE THERAPEUTICS plc Healthcare
SHS

Stephen H. Sands

Director
Lexington, MA

Track Institutional and Insider Activities on CYT

Follow Cyteir Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYT shares.

Notify only if

Insider Trading

Get notified when an Cyteir Therapeutics, Inc. insider buys or sells CYT shares.

Notify only if

News

Receive news related to Cyteir Therapeutics, Inc.

Track Activities on CYT